Parents Confront Shock, Stigma, and Cost After Positive Newborn Sickle Cell Screening in Ghana
A positive newborn screen for sickle cell disease can change the first weeks of family life in an instant. At Korle Bu Teaching Hospital in Accra, parents described that moment as worry, surprise, or outright shock, especially when they had never seen the disease up close or did not understand its genetic basis. The emotional weight did not end with disclosure. It immediately shaped whether families told relatives, returned for follow-up, and could turn early diagnosis into ongoing care.
The qualitative study drew on interviews with 24 mothers and one father whose children were attending the pediatric sickle cell clinic at Korle Bu Teaching Hospital. Their children were between 7 months and 3 years 9 months old. Seventeen parents were married, five had more than one child enrolled in the clinic, and 10 said they or their partners had sickle cell disease. Interviews were conducted in English or Twi, transcribed verbatim, and organized into themes using NVivo and Microsoft Word under a Socio-Ecological Model framework.
Emotional Reactions Were Shaped by Prior Knowledge and Personal Experience
Parents who already knew the disease, or had lived with it in the family, tended to absorb the diagnosis with more context. Others encountered the result as an abrupt threat to a newborn they had just brought home. The contrast matters clinically because newborn screening only works when the biological result is matched by timely comprehension and trust. A result alone does not create care; it can also create paralysis when families are unprepared for what it means.
Seven themes emerged from the interviews: emotional response after disclosure, decision to share results, care and management of newborns at home, knowledge of genetics of SCD, adherence to routine follow-up, cost, and culture. This pattern points to a familiar but often underestimated problem in screening programs. Early identification of disease is only the first step. The more fragile step is the transition from diagnosis to sustained engagement, where fear, social pressure, and financial strain can interrupt care long before complications appear.
Parents commonly received counseling and education on home care and the warning signs of sickle cell disease. Even so, the disclosure itself remained difficult. The diagnosis carried an immediate sense of uncertainty about the child’s future, and that uncertainty influenced how families responded in the days and weeks that followed.
Fear of Stigma Limited Disclosure Beyond the Household
Many parents hesitated to tell others about the positive result. Fear of stigmatization shaped that decision, suggesting that the social consequences of diagnosis can rival the medical burden. In a condition already associated with inherited risk and cultural misunderstanding, disclosure becomes a calculated choice rather than a simple act of sharing family news.
This is not a minor social detail. Sickle cell disease is a genetic disorder with lifelong implications, and families often become the first line of defense in recognizing fevers, dehydration, pain, and other warning signs. If parents feel they must keep the diagnosis hidden, they may lose access to the practical support that extended family and community networks can provide. Silence can also delay the kind of early reinforcement that helps maintain preventive routines.
Home Care Was Guided by Education, But Follow-Up Was Fragile
Most parents said they had been taught how to care for their newborns at home and how to recognize danger signs. Those instructions are especially important in the first years of life, when severe infections and sickling complications can escalate quickly. For newborns with confirmed disease or presumptive disease, the household becomes the site where hydration, prompt attention to fever, and consistent clinic attendance can alter the child’s trajectory.
Yet adherence to routine follow-up faltered. Parents wanted their children to remain healthy, but financial difficulty repeatedly interrupted attendance at clinic visits. The COVID-19 pandemic added another layer of disruption, compounding the practical barriers already present. The result was a familiar pattern in chronic pediatric care: initial acceptance of counseling followed by missed appointments when transport costs, competing family needs, and health-system strain collide.
Cost was not an abstract barrier in this cohort. It directly influenced whether families could sustain regular review, and that has consequences for a disease in which preventive care is designed to avert crises before they begin. In sickle cell care, missed follow-up is not simply missed paperwork. It means missed education, missed surveillance, and missed opportunities to intervene before complications become visible.
Genetic Understanding Remained Incomplete for Some Families
Knowledge of the genetics of sickle cell disease varied across the interviewed parents. Some understood the hereditary basis of the condition; others did not fully grasp how the diagnosis arose or what it meant for future pregnancies and family planning. That gap has direct implications for counseling, because the logic of newborn screening depends on more than confirming a child’s status. Families also need a clear explanation of inheritance, recurrence risk, and the role of both parents in transmission.
When genetic understanding is partial, the emotional and practical burden can intensify. Parents may interpret the result as an isolated misfortune rather than a predictable inherited condition. They may also struggle to explain the diagnosis to relatives or to make informed decisions about future screening and counseling within the family.
Culture and Health System Access Defined the Boundaries of Care
Culture emerged alongside cost as a structural barrier. In this study, cultural expectations influenced whether parents disclosed the diagnosis, how they interpreted it, and how they approached continued clinic care. In settings where inherited disease can carry blame or misunderstanding, culture does not sit outside the clinic door. It travels with the family into every follow-up visit and every conversation about the child’s future.
The findings also fit a larger public health gap in Ghana. Universal newborn screening for sickle cell disease is not fully implemented, and earlier screening efforts have shown a sharp drop between identifying positive babies and linking them to care. At Korle Bu Teaching Hospital, initial linkage efforts were strong in earlier screening periods, but acceptance and enrollment fell in later years even when positive cases were contacted. In that context, parental experience is not a secondary issue. It is part of the mechanism by which screening succeeds or fails.
For families, the diagnosis arrives first as an emotional shock, then as a series of decisions about disclosure, home care, and clinic attendance. For the health system, those same decisions determine whether newborn screening becomes early treatment or a missed opportunity. The study points to a need for broader public education about sickle cell disease, stronger psychological support for parents, and socioeconomic help that can keep families connected to care after the first positive result.